These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 30914434)

  • 1. Interactions of
    Lin HY; Callan CY; Fang Z; Tung HY; Park JY
    Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1067-1075. PubMed ID: 30914434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer risk associated loci in African Americans.
    Xu J; Kibel AS; Hu JJ; Turner AR; Pruett K; Zheng SL; Sun J; Isaacs SD; Wiley KE; Kim ST; Hsu FC; Wu W; Torti FM; Walsh PC; Chang BL; Isaacs WB
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2145-9. PubMed ID: 19549807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphism and prostate cancer aggressiveness: a case-only study of 1,536 GWAS and candidate SNPs in African-Americans and European-Americans.
    Bensen JT; Xu Z; Smith GJ; Mohler JL; Fontham ET; Taylor JA
    Prostate; 2013 Jan; 73(1):11-22. PubMed ID: 22549899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of lncRNA CASC8, CASC11, and PVT1 Genetic Variants to the Susceptibility of Coronary Heart Disease.
    Lu Y; Yuan W; Wang L; Ning M; Han Y; Gu W; Zhao T; Shang F; Guo X
    J Cardiovasc Pharmacol; 2021 Jun; 77(6):756-766. PubMed ID: 34001726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GWAS SNP Replication among African American and European American men in the North Carolina-Louisiana prostate cancer project (PCaP).
    Xu Z; Bensen JT; Smith GJ; Mohler JL; Taylor JA
    Prostate; 2011 Jun; 71(8):881-91. PubMed ID: 21456070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry.
    Yuan J; Kensler KH; Hu Z; Zhang Y; Zhang T; Jiang J; Xu M; Pan Y; Long M; Montone KT; Tanyi JL; Fan Y; Zhang R; Hu X; Rebbeck TR; Zhang L
    PLoS Genet; 2020 Feb; 16(2):e1008641. PubMed ID: 32059012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple independent genetic variants in the 8q24 region are associated with prostate cancer risk.
    Salinas CA; Kwon E; Carlson CS; Koopmeiners JS; Feng Z; Karyadi DM; Ostrander EA; Stanford JL
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1203-13. PubMed ID: 18483343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans.
    Sun J; Purcell L; Gao Z; Isaacs SD; Wiley KE; Hsu FC; Liu W; Duggan D; Carpten JD; Grönberg H; Xu J; Chang BL; Partin AW; Walsh PC; Isaacs WB; Zheng SL
    Prostate; 2008 May; 68(7):691-7. PubMed ID: 18361410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide two-locus epistasis scans in prostate cancer using two European populations.
    Tao S; Feng J; Webster T; Jin G; Hsu FC; Chen SH; Kim ST; Wang Z; Zhang Z; Zheng SL; Isaacs WB; Xu J; Sun J
    Hum Genet; 2012 Jul; 131(7):1225-34. PubMed ID: 22367438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of MYC is strongly dependent on the circular PVT1 expression in pure Gleason pattern 4 of prostatic cancer.
    Umemori M; Kurata M; Yamamoto A; Yamamoto K; Ishibashi S; Ikeda M; Tashiro K; Kimura T; Sato S; Takahashi H; Kitagawa M
    Med Mol Morphol; 2020 Sep; 53(3):156-167. PubMed ID: 31932969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CASC11 promotes aggressiveness of prostate cancer cells through miR-145/IGF1R axis.
    Capik O; Sanli F; Kurt A; Ceylan O; Suer I; Kaya M; Ittmann M; Karatas OF
    Prostate Cancer Prostatic Dis; 2021 Sep; 24(3):891-902. PubMed ID: 33753875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine-mapping IGF1 and prostate cancer risk in African Americans: the multiethnic cohort study.
    Giorgi EE; Stram DO; Taverna D; Turner SD; Schumacher F; Haiman CA; Lum-Jones A; Tirikainen M; Caberto C; Duggan D; Henderson BE; Le Marchand L; Cheng I
    Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1928-32. PubMed ID: 24904019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine-mapping of IL16 gene and prostate cancer risk in African Americans.
    Batai K; Shah E; Murphy AB; Newsome J; Ruden M; Ahaghotu C; Kittles RA
    Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2059-68. PubMed ID: 22923025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide two-locus interaction analysis identifies multiple epistatic SNP pairs that confer risk of prostate cancer: A cross-population study.
    Shen J; Li Z; Song Z; Chen J; Shi Y
    Int J Cancer; 2017 May; 140(9):2075-2084. PubMed ID: 28124475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP.
    Duggan D; Zheng SL; Knowlton M; Benitez D; Dimitrov L; Wiklund F; Robbins C; Isaacs SD; Cheng Y; Li G; Sun J; Chang BL; Marovich L; Wiley KE; Bälter K; Stattin P; Adami HO; Gielzak M; Yan G; Sauvageot J; Liu W; Kim JW; Bleecker ER; Meyers DA; Trock BJ; Partin AW; Walsh PC; Isaacs WB; Grönberg H; Xu J; Carpten JD
    J Natl Cancer Inst; 2007 Dec; 99(24):1836-44. PubMed ID: 18073375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer.
    Wang Y; Freedman JA; Liu H; Moorman PG; Hyslop T; George DJ; Lee NH; Patierno SR; Wei Q
    Int J Cancer; 2017 Aug; 141(4):731-743. PubMed ID: 28510291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.
    Lindstrom S; Schumacher F; Siddiq A; Travis RC; Campa D; Berndt SI; Diver WR; Severi G; Allen N; Andriole G; Bueno-de-Mesquita B; Chanock SJ; Crawford D; Gaziano JM; Giles GG; Giovannucci E; Guo C; Haiman CA; Hayes RB; Halkjaer J; Hunter DJ; Johansson M; Kaaks R; Kolonel LN; Navarro C; Riboli E; Sacerdote C; Stampfer M; Stram DO; Thun MJ; Trichopoulos D; Virtamo J; Weinstein SJ; Yeager M; Henderson B; Ma J; Le Marchand L; Albanes D; Kraft P
    PLoS One; 2011 Feb; 6(2):e17142. PubMed ID: 21390317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a genetic variant in CYP3A4 on risk and clinical presentation of prostate cancer among white and African-American men.
    Bangsi D; Zhou J; Sun Y; Patel NP; Darga LL; Heilbrun LK; Powell IJ; Severson RK; Everson RB
    Urol Oncol; 2006; 24(1):21-7. PubMed ID: 16414488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EphB2 SNPs and sporadic prostate cancer risk in African American men.
    Robbins CM; Hooker S; Kittles RA; Carpten JD
    PLoS One; 2011; 6(5):e19494. PubMed ID: 21603658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KLK3 SNP-SNP interactions for prediction of prostate cancer aggressiveness.
    Lin HY; Huang PY; Cheng CH; Tung HY; Fang Z; Berglund AE; Chen A; French-Kwawu J; Harris D; Pow-Sang J; Yamoah K; Cleveland JL; Awasthi S; Rounbehler RJ; Gerke T; Dhillon J; Eeles R; Kote-Jarai Z; Muir K; ; Schleutker J; Pashayan N; ; Neal DE; Nielsen SF; Nordestgaard BG; Gronberg H; Wiklund F; Giles GG; Haiman CA; Travis RC; Stanford JL; Kibel AS; Cybulski C; Khaw KT; Maier C; Thibodeau SN; Teixeira MR; Cannon-Albright L; Brenner H; Kaneva R; Pandha H; ; Srinivasan S; Clements J; Batra J; Park JY
    Sci Rep; 2021 Apr; 11(1):9264. PubMed ID: 33927218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.